Impaired inducibility of immune regulatory capacity of peripheral B cells of patients with recurrent pregnancy loss
- PMID: 39495420
- DOI: 10.1007/s12026-024-09549-7
Impaired inducibility of immune regulatory capacity of peripheral B cells of patients with recurrent pregnancy loss
Abstract
The pathogenesis of recurrent pregnancy loss (RPL) is unclear. RPL may have an association with disruption of immune tolerance. The aim of this study is to characterize the inducibility of immune regulatory ability in peripheral naïve B cells of patients with RPL. In this study, blood samples were taken from patients with RPL. B220+ B cells were isolated by flow cytometry cell sorting. The gene profile of B cells was analyzed using RNA sequencing (RNAseq). The results showed that peripheral B220+ B cells of RPL patients had lower expression of IL10 and exacerbated ER stress. The induction of IL10 expression in peripheral B220+ B cells of RPL patients were impaired. High ubiquitination of c-Maf inducing protein (CMIP) was detected in RPL B cells. Exposure to thapsigargin (an ER stress agonist) decreased the amount of CMIP in B cells. The effects of ER stress on reducing CMIP quantity in B cells were mediated by the histone H2B E3 ubiquitin ligase ring finger protein 20 (RNF20). Inhibition of RNF20 or ER stress restored the inducibility of immune regulatory functions of B220+ B cells of RPL patients. In summary, peripheral B cells in patients with RPL show impaired immune regulation capacity, in which exacerbated ER stress plays a crucial role. Regulation of ER stress or inhibition of RNF20 can restore the immune regulatory capacity in the B cells.
Keywords: B cell; Endoplasmic reticulum stress; Immune regulation; Interleukin 10; Recurrent pregnancy loss.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98. https://doi.org/10.1038/s41572-020-00228-z . - DOI - PubMed
-
- Zhuang B, Shang J, Yao Y. HLA-G: an important mediator of maternal-fetal immune-tolerance. Front Immunol. 2021;12: 744324. https://doi.org/10.3389/fimmu.2021.744324 . - DOI - PubMed - PMC
-
- Rosser EC, Mauri C. The emerging field of regulatory B cell immunometabolism. Cell Metab. 2021;33(6):1088–97. https://doi.org/10.1016/j.cmet.2021.05.008 . - DOI - PubMed
-
- Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in egulatory B cells. Cell Metab. 2020;31(4):837-e5110. https://doi.org/10.1016/j.cmet.2020.03.003 . - DOI - PubMed - PMC
-
- Larson C, Oronsky B, Carter CA, Oronsky A, Knox SJ, Sher D, et al. TGF-beta: a master immune regulator. Expert Opin Ther Targets. 2020;24(5):427–38. https://doi.org/10.1080/14728222.2020.1744568 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials